Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update
Connect Biopharma Reports Second Quarter 2025 Financial Results and Provides Business Update GlobeNewswire August 13, 2025 – Initiated Phase 2 Seabreeze STAT asthma and COPD studies evaluating rademikibart as an adjunct treatment for acute exacerbations – – Presented positive data at ATS 2025 and EAACI 2025 supporting the potential of rademikibart to deliver differentiated efficacy […]